128 related articles for article (PubMed ID: 31453897)
1. Effect of Long-term Oral Steroids on Intraocular Pressure in Children With Autoimmune Hepatitis: a Prospective Cohort Study.
Prasad D; Poddar U; Kanaujia V; Yachha SK; Srivastava A
J Glaucoma; 2019 Oct; 28(10):929-933. PubMed ID: 31453897
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Ocular Steroid Hypertensive Response in Children.
Kaur S; Dhiman I; Kaushik S; Raj S; Pandav SS
J Glaucoma; 2016 Apr; 25(4):343-7. PubMed ID: 25651206
[TBL] [Abstract][Full Text] [Related]
3. Elevated intraocular pressure associated with steroid treatment for infantile spasms.
Friling R; Weinberger D; Zeharia A; Lusky M; Mimouni M; Gaaton D; Snir M
Ophthalmology; 2003 Apr; 110(4):831-4. PubMed ID: 12689911
[TBL] [Abstract][Full Text] [Related]
4. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
[TBL] [Abstract][Full Text] [Related]
5. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
[TBL] [Abstract][Full Text] [Related]
6. Incidence, management and outcome of raised intraocular pressure in childhood-onset uveitis at a tertiary referral centre.
Tan SZ; Yau K; Steeples LR; Ashworth J; Fenerty C; Jones N
Br J Ophthalmol; 2019 Jun; 103(6):748-752. PubMed ID: 30021815
[TBL] [Abstract][Full Text] [Related]
7. Risk of ocular hypertension in children treated with systemic glucocorticoid.
Krag S; Larsen D; Albertsen BK; Glerup M
Acta Ophthalmol; 2021 Dec; 99(8):e1430-e1434. PubMed ID: 33629533
[TBL] [Abstract][Full Text] [Related]
8. Ocular-hypertensive response to topical steroids in children.
Kwok AK; Lam DS; Ng JS; Fan DS; Chew SJ; Tso MO
Ophthalmology; 1997 Dec; 104(12):2112-6. PubMed ID: 9400772
[TBL] [Abstract][Full Text] [Related]
9. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
[TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
[TBL] [Abstract][Full Text] [Related]
11. Frequency and management of raised intraocular pressure following intravitreal triamcinolone acetonide.
Mahar PS; Memon AS
J Coll Physicians Surg Pak; 2012 Nov; 22(11):699-702. PubMed ID: 23146849
[TBL] [Abstract][Full Text] [Related]
12. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.
Ng JS; Fan DS; Young AL; Yip NK; Tam K; Kwok AK; Lam DS
Ophthalmology; 2000 Nov; 107(11):2097-100. PubMed ID: 11054340
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dorzolamide/timolol versus brimonidine/timolol fixed combination therapy in the management of steroid-induced ocular hypertension.
Seymenoğlu G; Baser EF; Öztürk B; Gülhan C
J Glaucoma; 2015 Feb; 24(2):111-6. PubMed ID: 23807349
[TBL] [Abstract][Full Text] [Related]
14. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J;
Arch Ophthalmol; 2009 Feb; 127(2):173-8. PubMed ID: 19204235
[TBL] [Abstract][Full Text] [Related]
15. Ocular complications in children with nephrotic syndrome on long term oral steroids.
Gaur S; Joseph M; Nityanandam S; Subramanian S; Koshy AS; Vasudevan A; Phadke KD; Iyengar A
Indian J Pediatr; 2014 Jul; 81(7):680-3. PubMed ID: 24557606
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Intraocular Pressure Increases and Management Strategies Following Treatment With Fluocinolone Acetonide Intravitreal Implants in the FAME Trials.
Parrish RK; Campochiaro PA; Pearson PA; Green K; Traverso CE;
Ophthalmic Surg Lasers Imaging Retina; 2016 May; 47(5):426-35. PubMed ID: 27183546
[TBL] [Abstract][Full Text] [Related]
17. Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure.
Sheppard JD; Comstock TL; Cavet ME
Adv Ther; 2016 Apr; 33(4):532-52. PubMed ID: 26984315
[TBL] [Abstract][Full Text] [Related]
18. Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
Tseng JJ; Vance SK; Della Torre KE; Mendonca LS; Cooney MJ; Klancnik JM; Sorenson JA; Freund KB
J Glaucoma; 2012; 21(4):241-7. PubMed ID: 21423038
[TBL] [Abstract][Full Text] [Related]
19. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
Kass MA; Heuer DK; Higginbotham EJ; Johnson CA; Keltner JL; Miller JP; Parrish RK; Wilson MR; Gordon MO
Arch Ophthalmol; 2002 Jun; 120(6):701-13; discussion 829-30. PubMed ID: 12049574
[TBL] [Abstract][Full Text] [Related]
20. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
Frenkel MP; Haji SA; Frenkel RE
Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
